FRA:SBS • DE000STRA555
Overall SBS gets a fundamental rating of 5 out of 10. We evaluated SBS against 65 industry peers in the Health Care Equipment & Supplies industry. SBS has only an average score on both its financial health and profitability. SBS has a decent growth rate and is not valued too expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.72% | ||
| ROE | 6.67% | ||
| ROIC | 5.32% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.94% | ||
| PM (TTM) | 6.22% | ||
| GM | 29.65% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.49 | ||
| Debt/FCF | 41.27 | ||
| Altman-Z | 2.66 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.19 | ||
| Quick Ratio | 1.65 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.14 | ||
| Fwd PE | 10.49 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 75.83 | ||
| EV/EBITDA | 7.55 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.99% |
FRA:SBS (2/23/2026, 11:57:03 AM)
19.98
-0.42 (-2.06%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.99% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.14 | ||
| Fwd PE | 10.49 | ||
| P/S | 0.94 | ||
| P/FCF | 75.83 | ||
| P/OCF | 11.12 | ||
| P/B | 1.01 | ||
| P/tB | 1.93 | ||
| EV/EBITDA | 7.55 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.72% | ||
| ROE | 6.67% | ||
| ROCE | 7.38% | ||
| ROIC | 5.32% | ||
| ROICexc | 5.68% | ||
| ROICexgc | 8.34% | ||
| OM | 10.94% | ||
| PM (TTM) | 6.22% | ||
| GM | 29.65% | ||
| FCFM | 1.24% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.49 | ||
| Debt/FCF | 41.27 | ||
| Debt/EBITDA | 2.49 | ||
| Cap/Depr | 99.05% | ||
| Cap/Sales | 7.24% | ||
| Interest Coverage | 5.44 | ||
| Cash Conversion | 46.48% | ||
| Profit Quality | 20% | ||
| Current Ratio | 4.19 | ||
| Quick Ratio | 1.65 | ||
| Altman-Z | 2.66 |
ChartMill assigns a fundamental rating of 5 / 10 to SBS.DE.
ChartMill assigns a valuation rating of 5 / 10 to STRATEC SE (SBS.DE). This can be considered as Fairly Valued.
STRATEC SE (SBS.DE) has a profitability rating of 4 / 10.
The financial health rating of STRATEC SE (SBS.DE) is 5 / 10.
The Earnings per Share (EPS) of STRATEC SE (SBS.DE) is expected to decline by -11.28% in the next year.